Common Stock and Common Stock Purchase Warrants

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Common Stock and Common Stock Purchase Warrants

Note 15 — Common Stock and Common Stock Purchase Warrants

Common Stock

During the period ended March 31, 2022, 237,499 shares of common stock of the Company were issued upon exercise of stock options for cash of approximately $241. See Note 13, Stock-Based Compensation, for a discussion of the PAVmed Inc. 2014 Equity Plan. During the period ended, the PAVmed Inc. Employee Stock Purchase Plan purchased 194,240 shares of common stock of the Company. See Note 13, Stock-Based Compensation, for a discussion of the PAVmed Inc. Employee Stock Purchase Plan.

Common Stock Purchase Warrants

The common stock purchase warrants (classified in permanent equity) outstanding as of the dates indicated are as follows:

	Common Stock Purchase Warrants Issued and Outstanding
	March 31, 2022		Weighted Average Exercise Price / Share		December 31, 2021		Weighted Average Exercise Price / Share		Expiration Date
Series Z Warrants		11,937,450	$	1.60		11,937,455	$	1.60	April 2024
Series W Warrants		—	$	—		377,873	$	5.00	January 2022
Total		11,937,450	$	1.60		12,315,328	$	1.68

During the period ended March 31, 2022, a total of 5 Series Z Warrants were exercised for cash at $1.60 per share, resulting in the issue of the same number of shares of common stock of the Company.

The remaining 377,873 Series W Warrants expired unexercised as of January 29, 2022.